CLARIFY - In stable coronary disease, patients with angina and prior myocardial infarction have a poor prognosis despite adherence to guideline recommanded therapies. Final 5-year results from the CLARIFY study

SWEDEHEART: Secondary prevention medication after coronary artery bypass surgery and long-term mortality: A longitudinal population-based study from the SWEDEHEART registry

ICD use in HF - Association between implantable cardioverter-defibrillator use for primary prevention and mortality: a prospective propensity-score matched study

PURE: Impact of modifiable risk factors on cardiovascular disease and mortality

RAPIDTnT: A randomised trial of a 1-hour troponin T protocol in suspected acute coronary syndromes: the Rapid Assessment of Possible ACS In the emergency Department with high sensitivity Troponin T

ENTRUST-AF PCI - Edoxaban-based versus vitamin-K-antagonist-based anti-thrombotic regimen following successful coronary stenting in atrial fibrillation patients.

POPular Genetics - Genotype-guided oral P2Y12-inhibition in patients with St-segment elevation myocardial infarction undergoing primary PCI : a randomized, open-label, multicenter trial

Combined effect of lower LDL-C and lower SBP on the lifetime risk od cardiovascular disease

AFIRE - Rivaroxaban monotherapy versus dual therapy in patients with atrial fibrillation and stable coronary artery disease

GALACTIC - Goal-directed AfterLoad Reduction in Acute Congestive Cardiac Decompensation: a randomized controlled trial

Salt substitution and community-wide reduction in blood pressure and hypertension incidence

HOPE 4 - Impact on cardiovascular risk of a community based multifaceted intervention in individuals with hypertension in 2 middle income countries: The Heart Outcomes Prevention and Evaluation 4 study

SYNTAXES: Ten-Year Survival after Coronary Artery Bypass Grafting versus Percutaneous Coronary Intervention: The SYNTAX Extended Survival study

MITRA-FR - 2 years follow-Up of the MITRA-FR study a randomized controlled trial evaluating the effectiveness of percutaneous mitral valve repair in secondary mitral regurgitation

DAPA HF The Dapagliflozin And Prevention Of Adverse-outcomes In Heart Failure Trial

CONDI-2/ERIC-PPCI Effect of remote ischemic conditioning on clinical outcomes in patients with Stsegment elevation myocardial infarction undergoing primary percutaneous coronary intervention

RAPID‑TnT ‑ A randomised trial of a 1‑hour troponin T protocol in suspected acute coronary syndromes: the Rapid Assessment of Possible ACS In the emergency Department with high sensitivity Troponin T

POPular Genetics - Genotype- guided oral P2Y12-inhibition in patients with St-segment elevation myocardial infraction undergoing primary PCI: a randomized, open-label, multicenter trial

Long-term outcome of the Defibrillator After Primary Angioplasty Trial - Implantable Defibrillator Early After Primary Percutaneous Intervention for ST- Elevation Myocardial infraction

ENTRUST‑AF PCI ‑ Edoxaban‑based versus vitamin‑K‑ antagonist‑based anti‑thrombotic regimen following successful coronary stenting in atrial fibrillation patients

Differences in the management and outcomes in congenital versus acquired heart disease

ESC Congress Highlights

Late Breaking Science in Cardiovascular Pharmacology

PURE Study

The CLARIFY study

Controversies in secondary  prevention: treating residual risk

ESC 2019 Guidelines

How wider use of combinations will improve control of the main cardiovascular risk factors

How wider use of combinations will improve control of the main cardiovascular risk factors

Lipid and Blood pressure lowering

HOPE 4 ‑ Impact on cardiovascular risk of a community‑based multi‑faceted intervention in individuals with hypertension in 2 middle income countries: The Heart Outcomes Prevention and Evaluation 4 study

Combinations of beta-blockers and angiotensin-converting enzyme inhibitors: what is the rationale?